• ქართული
  • English
  • Japan's Takeda sweetens $62 billion Shire offer

    TOKYO/LONDON (Reuters) – Japan’s Takeda Pharmaceutical nudged up its offer for Shire to 44.3 billion pounds ($62 billion) on Friday to try to persuade the rare-disease drugs specialist into talks after it rejected three previous proposals.

    Market Quotes by TradingView